The scope of work for this contract includes the development and validation of biotin as an in vivo labelling agent for red blood cells to replace chromium 51 as the standard FDA-approved technology…

Active Definitive Contract Awarded Last action

Contract number
75A50123C00052
Awardee
Awarding agency
Obligated
$8,406,883

Award facts

Opportunity
Contract value 100% obligated
$8,406,882.92 Current and potential, with all options
Completion date 78% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Cincinnati, OH 45221, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00007 $1,950,495
Other Administrative Action P00006 $0
Exercise an Option P00005 $2,079,738
Funding Only Action P00004 $502,361
Other Administrative Action P00003 $0
Other Administrative Action P00002 $0
Other Administrative Action P00001 $1,139,589
Original award $2,734,700

About this award

Written by GovTribe AI ·

The Office of the Assistant Secretary for Preparedness and Response awarded an $8.4 million definitive contract to Cincinnati Univ Of (Sponsored Research Services Division) on September 21, 2023, for development and validation of biotin as an in vivo labeling agent for red blood cells to replace chromium-51 in assessing red blood cell lifespan in circulation, with performance through September 30, 2027.

Place of performance is Cincinnati, OH. The work originates from a Biomedical Advanced Research and Development Authority (BARDA) broad agency announcement posted October 16, 2017, which solicited advanced research and development of medical countermeasures against chemical, biological, radiological, nuclear, and pandemic influenza threats. Cincinnati University's Sponsored Research Services Division is a state-controlled public research institution operating as a prime federal research contractor and grant recipient across biomedicine, environmental science, and engineering.

Subcontractors include Dana-Farber Cancer Institute (clinical trial coordination and biospecimen services), Vitalant Research Institute (transfusion medicine and blood product research), The American National Red Cross (blood product testing and regulatory support), Children's Hospital Medical Center (pediatric clinical research), and Zalgen Labs LLC (antibody and diagnostic development). Cincinnati University invoiced $768 thousand in FY2024 under this contract with no subcontractor labor reported; work was self-performed.

Description

As the agency reported it.

The scope of work for this contract includes the development and validation of biotin as an in vivo labelling agent for red blood cells to replace chromium 51 as the standard FDA-approved technology for assessing the lifespan of rbcs in circulation.

Subawards

Subcontractor Amount Awarded
Dana-Farber Cancer Institute, Inc. THE SCOPE OF WORK FOR THIS CONTRACT INCLUDES THE DEVELOPMENT AND VALIDATION OF BIOTIN AS AN IN VIVO LABELLING AGENT FOR RED BLOOD CELLS TO REPLACE CHROMIUM 51… $58,953
Dana-Farber Cancer Institute, Inc. THE SCOPE OF WORK FOR THIS CONTRACT INCLUDES THE DEVELOPMENT AND VALIDATION OF BIOTIN AS AN IN VIVO LABELLING AGENT FOR RED BLOOD CELLS TO REPLACE CHROMIUM 51… $22,551
The American National Red Cross THE SCOPE OF WORK FOR THIS CONTRACT INCLUDES THE DEVELOPMENT AND VALIDATION OF BIOTIN AS AN IN VIVO LABELLING AGENT FOR RED BLOOD CELLS TO REPLACE CHROMIUM 51… $150,741
Zalgen Labs LLC THE SCOPE OF WORK FOR THIS CONTRACT INCLUDES THE DEVELOPMENT AND VALIDATION OF BIOTIN AS AN IN VIVO LABELLING AGENT FOR RED BLOOD CELLS TO REPLACE CHROMIUM 51… $149,552
Vitalant THE SCOPE OF WORK FOR THIS CONTRACT INCLUDES THE DEVELOPMENT AND VALIDATION OF BIOTIN AS AN IN VIVO LABELLING AGENT FOR RED BLOOD CELLS TO REPLACE CHROMIUM 51… $404,479
Childrens Hospital Medical Center THE SCOPE OF WORK FOR THIS CONTRACT INCLUDES THE DEVELOPMENT AND VALIDATION OF BIOTIN AS AN IN VIVO LABELLING AGENT FOR RED BLOOD CELLS TO REPLACE CHROMIUM 51… $41,881

Quick answers

Who was awarded contract 75A50123C00052?

75A50123C00052 was awarded to Cincinnati Univ Of by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 21, 2023.

How much is contract 75A50123C00052 worth?

The government has obligated $8,406,883 on 75A50123C00052.

Was contract 75A50123C00052 competed?

The extent of competition for 75A50123C00052 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login